Page last updated: 2024-12-06

dehydrosanol

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

dehydrosanol: structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID72070
CHEMBL ID2104003
CHEBI ID135640
SCHEMBL ID564338
MeSH IDM0055369

Synonyms (32)

Synonym
1824-52-8
bemetizide
dehydrosanol
2h-1,2,4-benzothiadiazine, 3,4-dihydro-6-chloro-3-(alpha-methylbenzyl)-7-sulfamoyl-, 1,1-dioxide
brn 0631888
einecs 217-357-5
6-chlor-3,4-dihydro-3-(alpha-methylbenzyl)-7-sulfamoyl-2h-1,2,4-benzothiadiazine-1,1-dioxide
bemetizid
6-chloro-3,4-dihydro-3-(alpha-methylbenzyl)-2h-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide
bemetizidum [inn-latin]
pertensosanol
diu 60
bemetizide [inn:ban]
bemeticide
su 7078
bemetizida [inn-spanish]
CHEBI:135640
bemetizidum
ezn4d2o31b ,
bemetizida
unii-ezn4d2o31b
CHEMBL2104003
SCHEMBL564338
bemetizide [mart.]
6-chloro-3,4-dihydro-3-(.alpha.-methylbenzyl)-2h-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide
bemetizide [inn]
bemetizide [who-dd]
Q27277448
6-chloro-1,1-dioxo-3-(1-phenylethyl)-3,4-dihydro-2h-1lambda6,2,4-benzothiadiazine-7-sulfonamide
DTXSID301021632
DTXSID30862759
6-chloro-1,1-dioxo-3-(1-phenylethyl)-1,2,3,4-tetrahydro-1lambda~6~,2,4-benzothiadiazine-7-sulfonamide

Research Excerpts

Compound-Compound Interactions

ExcerptReferenceRelevance
"The optimal daily dose and dose regimen of a new drug combination (Pertenso), consisting of 10 mg bemetizide, 20 mg triamterene, 20 mg dihydralazine and 20 mg bupranolol were tested in 14 hypertensive outpatients (WHO I to III) in a single blind crossover trial."( [Treatment of hypertension with a drug combination, consisting of bemetizide, triamterene, dihydralazine and bupranolol (author's transl)].
Brandstetter, G; Gasser, RW; Skrabal, F, 1982
)
0.26

Dosage Studied

ExcerptRelevanceReference
" Thus, this long-term study provides additional evidence that diuretics have a flat dose-response curve with respect to their antihypertensive efficacy, whereas lower doses might cause less pronounced activation of counter-regulatory systems."( Long-term diuretic therapy: effects of dose reduction on antihypertensive efficacy and counterregulatory systems.
Ripka, O; Weisser, B, 1992
)
0.28
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
benzothiadiazineHeterocyclic compound of a ring with sulfur and two nitrogen atoms fused to a benzene ring. Members inhibit sodium-potassium-chloride symporters and are used as diuretics.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (18)

TimeframeStudies, This Drug (%)All Drugs %
pre-199015 (83.33)18.7374
1990's2 (11.11)18.2507
2000's0 (0.00)29.6817
2010's1 (5.56)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 32.03

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index32.03 (24.57)
Research Supply Index3.40 (2.92)
Research Growth Index4.13 (4.65)
Search Engine Demand Index36.59 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (32.03)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials9 (45.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies1 (5.00%)4.05%
Observational0 (0.00%)0.25%
Other10 (50.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]